Press release
Adrenocorticotropic Hormone (Acth) Market is Expected to Surpass ~US$ 2.1 Bn Mark by the End of 2027v
According to the report, the global adrenocorticotropic hormone (ACTH) market was valued at US$ 1.47 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. Multiple applications and rise in number of patients with chronic diseases are the major factors anticipated to drive the global adrenocorticotropic hormone (ACTH) market from 2019 to 2027.
Read Report Overview - https://www.transparencymarketresearch.com/adrenocorticotropic-hormone-market.html
Multiple Applications and Rise in Prevalence of Chronic Diseases to Drive Global Market
H.P. Acthar Gel was the primary corticotropin product from Questcor Pharmaceuticals, Inc., which was acquired by Mallinckrodt in August 2014. The U.S. FDA approved Acthar for the treatment of 19 indications. The rate of infantile spasm is estimated to be 2.5 to 6.0 cases per 10,000 live births. Its prevalence rate is 1.5 to 2.0 cases per 10,000 children aged 10 years or younger, based on data published in the National Organization for Rare Disorders, Inc. According to the Centers for Disease Control and Prevention (CDC), about 23% adults in the U.S., which is more than 54 million people, have arthritis. The disease is expected to affect 78 million adults in the country by 2040.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76241
According to data published in the National Center for Biotechnology Information in 2019, the estimated prevalence of polymyositis and dermatomyositis (PM/DM) is 5 to 22 per 100,000 people, and approximately 1.2 million to 1.9 million persons are at risk per year. Adrenocorticotropic hormone (ACTH) as a treatment for proteinuria due to nephrotic syndrome (NS) has re-emerged in the last decade.
Nephrotic syndrome is one of the most common chronic renal diseases in children. It has an incidence of 2 to 7 per 100,000 population and a prevalence of 16 per 100,000, well above the 1 per 1 million incidence of chronic renal failure in children. Hence, rise in cases of target diseases and applications of corticotropin in various indications boost the growth of the global market.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=76241
Rheumatology to Offer Lucrative Opportunities
The report offers detailed segmentation of the global adrenocorticotropic hormone (ACTH) market based on source, indication, distribution channel, and region. In terms of source, the global adrenocorticotropic hormone (ACTH) market has been bifurcated into natural and synthetic. Based on indication, the global market has been classified into rheumatology, neurology, nephrotic syndrome, ophthalmology, and others. Arthritis is a chronic autoimmune disorder that causes flare up, stiffness, and swelling in the joints, especially in the lower extremities.
Common types of arthritis are osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and gout. Arthritis is a wide term covering around 100 types of joint diseases. Several patients with psoriasis develop arthritis. All these factors are expected to drive the rheumatology segment. In terms of distribution channel, the global adrenocorticotropic hormone (ACTH) market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. Rise in adoption of e-Commerce is anticipated to propel the online pharmacies segment in the near future.
Request for Analysis of COVID-19 Impact on Adrenocorticotropic Hormone (ACTH) Market -https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76241
North America to Lead Adrenocorticotropic Hormone (ACTH) Market
North America dominated the global adrenocorticotropic hormone (ACTH) market in 2018 and the trend is likely to continue during the forecast period. North America’s dominance of the global market is attributed to high rate of adoption of Acthar Gel in a number of indications as well as high cost of the drug in the country. The market in Europe is projected to expand at a CAGR of 3.5% from 2019 to 2027. Increase in awareness about various diseases, favorable medical reimbursement policies, availability of synthetic ACTH (tetracosactide), and well-established healthcare facilities are the major factors anticipated to drive the market in Europe during the forecast period.
Key Players in Global Market
The report provides profiles of leading players operating in the global adrenocorticotropic hormone (ACTH) market. These include Mallinckrodt plc, Pfizer, Inc., Novartis AG, Mylan N.V., and Hikma Pharmaceuticals plc. Mallinckrodt Pharmaceuticals is an Ireland-based manufacturer of specialty pharmaceuticals, generic drugs, and imaging agents.
Buy Adrenocorticotropic Hormone (ACTH) Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=76241<ype=S
The company manufactures and distributes products, including active pharmaceutical ingredients, contrast products, and radiopharmaceuticals, used for diagnostic tests and treatment for pain-related conditions. In August 2014, Questcor Pharmaceuticals, Inc. (manufacturer of Acthar Gel) was acquired by Mallinckrodt Pharmaceuticals.
Browse More Trending Reports by Transparency Market Research –
Radiation Therapy Market: https://www.prnewswire.com/news-releases/global-radiation-therapy-market-to-reach-us-8-6-bn-by-2026--product-approvals-to-drive-growth-transparency-market-research-300998453.html
Radiodermatitis Market: https://www.prnewswire.com/news-releases/surging-cases-of-cancer-to-drive-growth-of-the-global-radiodermatitis-market-tmr-301213939.html
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adrenocorticotropic Hormone (Acth) Market is Expected to Surpass ~US$ 2.1 Bn Mark by the End of 2027v here
News-ID: 2368057 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for ACTH
ACTH ELISA Test Kit Market Key Players, Share and Forecast Outlook
"The global market for ACTH ELISA test kits is valued at approximately $150 million in 2024, with a projected value of around $280 million by 2034. This represents a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period from 2025 to 2034. "
Exactitude Consultancy., Ltd. released a research report titled "ACTH ELISA Test Kit Market". This report covers the global ACTH ELISA Test Kit market sales, sales…
Innovative Horizons in the ACTH (1-39) Market: Trends and Leading Players
In today's dynamic global economy, the ACTH (1-39) market is emerging as a beacon of opportunity and innovation. With rapid technological advancements, evolving consumer demands, and proactive government policies shaping the landscape, this sector is setting the stage for transformative change. Our in-depth analysis delves into historical market trends, current dynamics, and future projections, providing industry leaders, investors, and decision-makers with the strategic insights needed to navigate this competitive terrain.
𝐆𝐞𝐭…
ACTH Deficiency Market is growing at a healthy CAGR 7.00% by 2028
Global ACTH Deficiency market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR 7.00% in the above-mentioned research forecast period. Rising prevalence of rare disorders such as Addison Disease, Gigantism, Cushing Syndrome, Childhood Obesity and others are the factors responsible for the growth of this market.
However, a rising population with unhealthy lifestyles…
Adrenocorticotropic Hormone [ACTH] Market to Record an Exponential CAGR by 2031
Adrenocorticotropic Hormone (ACTH) Market: Introduction
According to the report, the global adrenocorticotropic hormone (ACTH) market was valued at US$ 1.3 Bn in 2020 and is projected to expand at a CAGR of 3.9% from 2021 to 2031. Need for the development of newer and technologically enhanced products is rising globally, owing to treatment efficiency of drugs. Hence, major players operating in the market invest in research & development in order to develop new drugs. The rise in…
Adrenocorticotropic Hormone (ACTH) Market 2022: Mallinckrodt, Pfizer, Novartis A …
Adrenocorticotropic Hormone (ACTH) Market research report studies the competitive development of the market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, it provides a region-wise study of the market, including North America, Asia Pacific, Latin America, the Middle East, Africa, and Europe. As a result, it helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength,…
ACTH Deficiency Treatment Market Analysis & Key Business Strategies by Leading I …
Adenocorticotropic hormone (ACTH) is produced and secreted by anterior pituitary gland. It is also called corticotropin, serum ACTH, etc. The hormone’s function is to regulate the levels of steroid hormone cortisol which is regulated by adrenal gland. ACTH is associated with diseases such as pituitary tumors and adrenal malfunctions. Deficiency of ACTH arises due to the absence or decreased production of adrenocorticotropic hormone, which leads to adrenal insufficiency. This results…
